Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Issue: COVID
Remove filter for
Type: Alert
Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 15 items.
EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…
AlertHealth professional risk communication | 2022-04-14
NUVAXOVID was authorized by Health Canada on February 17, 2022. In order to provide earlier access to NUVAXOVID in the context of the global pandemic, Novavax, Inc. will distribute product vials, cartons and package inserts that are in English only for a…
AlertHealth professional risk communication | 2022-02-23
UPDATED INFORMATION - July 6, 2022
A new PAXLOVID dose pack for use in patients with moderate renal impairment (eGFR ≥30 to <60 mL/min) is now available with a distinct DIN: 02527804. Pfizer has introduced this new packaging configuration to…
AlertHealth professional risk communication | 2022-01-17
Hand sanitizers labelled as "Anti-Microbe" and/or with DIN 02248351 recalled because they may pose health risks, particularly to children
Starting date:
January 22,…
AlertPublic advisory | 2021-01-22
Importation of German-labelled Hydromorphon Ethypharm Kalceks (Hydromorphone Hydrochloride Solution for Injection) due to Potential Shortage of Canadian-labelled HYDROmorphone…
AlertHealth professional risk communication | 2021-01-06
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
Starting date:
September 8, 2020
Posting date:
September 15…
AlertHealth professional risk communication | 2020-09-15
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
Starting date:
July 28, 2020
Type of communication:
Advisory…
AlertPublic advisory | 2020-07-28
Risk of poisoning from hand sanitizers sold in beverage containers
Starting date:
June 10, 2020
Posting date:
June 10, 2020
Type of communication:
Advisory
Subcategory:
Drugs…
AlertPublic advisory | 2020-06-10
Health Canada advises Canadians to help support the continued supply of medications
Starting date:
June 1, 2020
Type of communication:
Advisory
Subcategory:
Drugs
Source of…
AlertPublic advisory | 2020-06-01
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
Starting date:
April 25, 2020
Posting…
AlertInformation update | 2020-04-25
Shortage of salbutamol inhalers in Canada
Starting date:
April 17, 2020
Type of communication:
Advisory
Subcategory:
Drugs
Source of recall:
Health Canada
Issue:
Supply…
AlertPublic advisory | 2020-04-17
Health Canada is temporarily authorizing the use of technical-grade ethanol in hand sanitizer products: Always follow the label directions when using alcohol-based hand sanitizers…
AlertPublic advisory | 2020-04-15
Homemade hand sanitizers may present health risks
Starting date:
April 2, 2020
Type of communication:
Advisory
Subcategory:
Drugs
Source of recall:
Health Canada
Issue:…
AlertPublic advisory | 2020-04-02
Stockpiling drugs can lead to local shortages: Canadians urged not to buy more medication than usual during the COVID-19 pandemic
Starting date:
March 30, 2020
Type of…
AlertPublic advisory | 2020-03-30
No scientific evidence that ibuprofen worsens COVID-19 symptoms
Starting date:
March 20, 2020
Type of communication:
Information Update
Subcategory:
Drugs
Source of recall:…
AlertInformation update | 2020-03-20